Effects of Tiaozhi mixture on lipid metabolism disorder in patients with chronic hepatitis C virus infection complicated with fatty liver
10.3760/cma.j.issn.1003-9279.2018.05.016
- VernacularTitle: 调脂合剂对慢性丙型肝炎病毒感染合并脂肪肝患者脂质代谢紊乱的影响
- Author:
Jing LI
1
;
Ping MIU
;
Juanjuan HUANG
;
Xianfeng CHEN
;
Jianyong WANG
Author Information
1. Department of Traditional Chinese Medicine, Ningbo Yinzhou People′s Hospital, Ningbo 315040, China
- Publication Type:Journal Article
- Keywords:
Chronic hepatitis C;
Fatty liver;
Tiaozhi mixture
- From:
Chinese Journal of Experimental and Clinical Virology
2018;32(5):525-528
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effects of Tiaozhi mixture on lipid metabolism disorder in patients with chronic hepatitis C virus infection and fatty liver.
Methods:The clinical data of 122 cases of patients with chronic hepatitis C virus infection and fatty liver admitted to our hospital from January 2016 to January 2017 were retrospectively analyzed. Control group was only given antiviral treatment, and observation group was given antiviral treatment and Tiaozhi mixture. The blood lipids parameters, decrease of HCV RNA load, negative conversion rate of serum anti-HCV.
Results:After treatment, the levels of blood lipids, i. e., triglycerides (TG), total cholesterol (TC) and low density lipoprotein-cholesterol (LDL-C) were decreased significantly in the two groups, and the decreases of blood lipid levels of TG, TC and LDL-C in observation group were greater than those in control group. The level of high density lipoprotein-colesterol (HDL-C) was increased significantly in observation group, and the level of HDL-C in control group was basically unchanged. The liver function tests for alanine aminotransferase (ALT) and total bile acid (TBA) levels were all decreased effectively, and the decrease in observation group was greater than that in control group, and the aspartate aminotransferase (AST) level in the two groups was reduced, but there was no significant difference between the two groups. The decrease of HCV RNA load and negative conversion rate of serum anti-HCV in observation group were higher than those in control group. There was no significant difference in the incidence rate of adverse reactions between the two groups after treatment(χ2=0.000, P=1.000).
Conclusions:In the clinical treatment of chronic hepatitis C virus infection with fatty liver, combined Tiaozhi mixture can effectively increase the antiviral efficacy, reduce the possibility of adverse reactions, and help patients with liver function recovery, and it has high safety. Thus it is worthy of clinical promotion.
